| scholarly article | Q13442814 |
| P2093 | author name string | McCALL MS | |
| MADISON LL | |||
| UNGER RH | |||
| EISENTRAUT AM | |||
| P2860 | cites work | Some aspects of the glucagon problem | Q78634594 |
| Purification and crystallization of glucagon | Q78691213 | ||
| Isotopic tracers in the study of diabetes | Q79156650 | ||
| Glucagon antibodies and their use for immunoassay for glucagon | Q79293764 | ||
| Immunoassay of endogenous plasma insulin in man | Q22306302 | ||
| Nonprecipitating insulin antibodies | Q33708733 | ||
| Insulin-I131 metabolism in human subjects: demonstration of insulin binding globulin in the circulation of insulin treated subjects | Q35296645 | ||
| The destruction of glucagon, adrenocorticotropin and somatotropin by human blood plasma | Q35635643 | ||
| Evidence for the insulin-directed specificity of rabbit anti-insulin serum | Q40994853 | ||
| Apparent inhibition of liver insulinase activity by serum and serum fractions containing insulin-binding antibody | Q41011919 | ||
| Quantitative aspects of the reaction between insulin and insulin-binding antibody | Q41012241 | ||
| An immunochemical assay of total extractable insulin in man. | Q41012629 | ||
| The zone of localization of antibodies. V. An attempt to saturate antibody-binding sites in mouse kidney | Q47975699 | ||
| The hyperglycaemic action of blood from animals treated with growth hormone. | Q51354280 | ||
| In vivo and in vitro metabolism of insulin-I 131 and glucagon-I 131 in normal and cortisone-treated rabbits | Q74422203 | ||
| Hypotensive reaction following the use of glucagon | Q74435277 | ||
| Assay for glucagon in rabbit plasma | Q78339639 | ||
| Presence of a glucagon-like material in blood of man and dog | Q78383219 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | antibody | Q79460 |
| glucagon | Q28163629 | ||
| P304 | page(s) | 1280-1289 | |
| P577 | publication date | 1961-07-01 | |
| P1433 | published in | Journal of Clinical Investigation | Q3186904 |
| P1476 | title | Glucagon antibodies and an immunoassay for glucagon | |
| P478 | volume | 40 |
| Q54077745 | A double antibody assay for glucagon |
| Q40051113 | A new bioassay for glucagon |
| Q24629428 | A noninvasive method to measure splanchnic glucose uptake after oral glucose administration |
| Q46927261 | A radioimmunoassay for diphenylhydantoin |
| Q79558858 | ACTH antibodies and their use for a radio-immunoassay for ACTH |
| Q47787170 | Adaptation of the human pancreas to inhibition of luminal proteolytic activity |
| Q40038923 | Aging and endocrine function--the pancreas |
| Q34560507 | Alpha cell function in health and disease: influence of glucagon-like peptide-1. |
| Q39617054 | Amino acid derangements in patients with sepsis: treatment with branched chain amino acid rich infusions |
| Q35871063 | An AlphaScreen Assay for the Discovery of Synthetic Chemical Inhibitors of Glucagon Production |
| Q43249927 | An enteroglucagon tumour |
| Q39938397 | Antibodies to Small Molecules: Biological and Clinical Applications |
| Q40319287 | Antibody to intrinsic factor in serum from patients with pernicious anemia |
| Q59095110 | Application of the Property of Protein-Binding to the Assay of Minute Quantities of Hormones and Other Substances |
| Q70126643 | Biliary response to glucagon in humans |
| Q40350637 | Characterization of response of circulating glucagon to intraduodenal and intravenous administration of amino acids |
| Q40349506 | Characterization of the responses of circulating glucagon-like immunoreactivity to intraduodenal and intravenous administration of glucose |
| Q69522747 | Cholecystokinin influences pancreatic trophism following total gastrectomy in rats |
| Q40682889 | Clearance of Immunoreactive Somatostatin by Perfused Rat Liver |
| Q77121531 | DISC ELECTROPHORESIS OF I-131-LABELED PROTEIN HORMONE PREPARATIONS AND THEIR REACTION PRODUCTS WITH ANTIBODIES |
| Q41274786 | Diabetic Ketoacidosis: Low-Dose Insulin Therapy by Various Routes |
| Q39993352 | Diagnostic biochemical methods in pancreatic disease. |
| Q66901388 | Distribution and properties of glucagon immunoreactivity in the digestive tract of various mammals: An immunohistochemical and immunochemical study |
| Q72811645 | Distribution of immunoassayable glucagon in gastrointestinal tissues |
| Q72532091 | Dynamics of insulin and glucagon secretion by the isolated perfused cat pancreas |
| Q39514768 | Effect of Glucagon Infusion on the Renal Clearance of Amylase Relative to Creatinine |
| Q69917695 | Effect of exogenous glucagon on pituitary polypeptide hormone release |
| Q44418265 | Effect of exogenously administered glucagon on plasma glucose levels in totally depancreatized dogs |
| Q72849706 | Effect of fibre from bran cereal on gastroenteropancreatic hormone responses of normal adults |
| Q54664109 | Effect of glutamine-supplemented intravenous nutrition on survival after Escherichia coli-induced peritonitis. |
| Q41642832 | Effects of insulin on the response of immunoreactive glucagon to an intravenous glucose load in human diabetes |
| Q72598222 | Effects of insulin on triglyceride and free fatty acid metabolism in man |
| Q70276415 | Effects of total pancreatectomy on the secretion of gut glucagon in humans |
| Q41627469 | Endocrine-metabolic relationships in patients with leprechaunism |
| Q34573587 | Enhancement of insulin action after oral glucose ingestion |
| Q24561425 | Evidence for decreased splanchnic glucose uptake after oral glucose administration in non-insulin-dependent diabetes mellitus |
| Q24536099 | Fasting: the history, pathophysiology and complications |
| Q42117172 | Gene expression of mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase in a poorly ketogenic mammal: effect of starvation during the neonatal period of the piglet. |
| Q39802337 | Glucagon and diabetes: A reappraisal |
| Q67355007 | Glucagon and insulin from lean rats and genetically obese fatty rats: Studies by radioimmunoassay, radioreceptorassay and bioassay |
| Q53781262 | Glucagon antibodies. |
| Q69133969 | Glucagon immunoassay using polyethylene glycol to precipitate antibody-bound hormone |
| Q39986637 | Glucagon in Medicine: New Ideas For an Old Hormone |
| Q68860843 | Glucagon lowers canine biliary cholesterol output at physiologic doses |
| Q51597423 | Glucagon, stress, and portal hypertension. Plasma glucagon levels and portal hypertension in relation to anesthesia and surgical stress. |
| Q34244209 | Glucagonocentric restructuring of diabetes: a pathophysiologic and therapeutic makeover |
| Q36189797 | Granulolysis in a cells of endocrine pancreas in spontaneous and experimental diabetes in animals |
| Q77921566 | Gut glucagon: A common receptor site with pancreatic glucagon in liver cell plasma membranes |
| Q37004850 | Hepatic and renal metabolism of somatostatin-like immunoreactivity. Simultaneous assessment in the dog |
| Q55450224 | High circulating concentrations of glucagon in non-anaemic uraemic patients |
| Q72132532 | High-fat diet in a short bowel syndrome. Intestinal absorption and gastroenteropancreatic hormone responses |
| Q93726844 | Hormonal control of carbohydrate metabolism |
| Q39916915 | Hormonal control of pancreatic endocrine and exocrine secretion |
| Q39820024 | How our food affects our hormones |
| Q51651360 | Human interdigestive and postprandial gastrointestinal motor and gastrointestinal hormone patterns. |
| Q34391769 | IMMUNOASSAY OF BOVINE AND HUMAN PARATHYROID HORMONE. |
| Q71488650 | Influence of Glucagon on Pancreatic Exocrine Secretion in Man |
| Q34553759 | Insulin and Glucagon: Partners for Life. |
| Q41498499 | Intestinal and pancreatic glucagon-like peptides. Evidence for identity of higher molecular weight forms |
| Q72216878 | Intestinal factors in insulin secretion, with special reference to the role of glucagon |
| Q72513997 | Is glucagon a choleretic hormone at physiologic blood levels? |
| Q46555370 | Is glucagon involved in cold acclimatization? |
| Q40319025 | Measurements of endogenous glucagon in plasma and the influence of blood glucose concentration upon its secretion |
| Q34270859 | Metabolic clearance and production rates of human luteinizing hormone in pre- and postmenopausal women |
| Q41373097 | Metabolic responses to enteral and parenteral nutrition |
| Q51791772 | Non-insulin-mediated glucose uptake predominates in postabsorptive dogs. |
| Q48908691 | Ontogenetic appearance of immunoreactive endocrine cells in rat pancreatic islets |
| Q34992826 | Pancreatic Islet-Cell Toxicity |
| Q70033732 | Paradoxical elevations of plasma glucagon levels in patients after pancreatectomy or gastrectomy |
| Q51639833 | Pharmacokinetics and metabolic effects of glibenclamide and glipizide in type 2 diabetics. |
| Q71050565 | Production of anti-glucagon antibodies in poly-L-lysine "responder" guinea-pigs |
| Q72358175 | Production of antibodies of high binding affinities to glucagon in rabbits |
| Q78289871 | RHABDOMYOSARCOMA OF THE BUTTOCK PRODUCING HYPOGLYCEMIA |
| Q51655637 | Radioimmunoassay for Pancreatic Glucagon Based on Specific Derivatisation of the Hormone |
| Q39916358 | Radioimmunoassay in Gastroenterology |
| Q39894122 | Radioimmunoassay of hormones and a critical review of its application to angiotensin assay |
| Q36456349 | Radioimmunoassayable glucagon levels in man: effects of starvation, hypoglycemia, and glucose administration |
| Q71146358 | Radioimmunological determination of pancreatic and gut glucagon in plasma |
| Q72203283 | Recent developments in the early diagnosis of hyperparathyroidism |
| Q38167833 | Sensitive glucagon quantification by immunochemical and LC-MS/MS methods |
| Q35576866 | Studies of pancreatic alpha cell function in normal and diabetic subjects |
| Q60017607 | The Origin and Understanding of the Incretin Concept |
| Q39149682 | The effect of glucagon on pancreatic secretion and plasma secretin in dogs |
| Q67042287 | The effect of short-term intravenous insulin administration on the glucagon response to a carbohydrate meal in adult onset and juvenile type diabetes |
| Q41013911 | The effects of secretin, pancreozymin, and gastrin on insulin and glucagon secretion in anesthetized dogs |
| Q40310502 | The effects of total starvation upon the levels of circulating glucagon and insulin in man. |
| Q40327871 | The experimental generation of antibodies to alpha-melanocyte stimulating hormone and adrenocorticotropic hormone |
| Q71847934 | The glucagon-like polypeptides - order out of chaos? |
| Q71646533 | The half-life of exogenous gastrin in the circulation |
| Q93761009 | The non specific effect of a serum factor on the radioimmunological insulin determination method of Hales and Randle |
| Q69807315 | The normal range of the plasma immunoreactive glucagon level during a 75 g oral glucose tolerance test |
| Q53976123 | The production of high-titre antibody against free angiotensin II. |
| Q27001704 | Unraveling oxyntomodulin, GLP1's enigmatic brother |
| Q72225706 | [Current theories concerning the physiological role of glucagon] |
Search more.